雜志介紹

Science Translational Medicine雜志介紹

《Science Translational Medicine》是一本以(yi)English為(wei)主的未開(kai)放獲取國際優秀期(qi)刊(kan)，中文名稱科(ke)學轉化(hua)醫學，本刊(kan)主要(yao)出版(ban)、報道(dao)醫學-CELL BIOLOGY領域的研(yan)究動(dong)態以(yi)及在該(gai)領域取得的各方面的經(jing)驗(yan)和科(ke)研(yan)成果，介紹該(gai)領域有關本專業的最新(xin)進(jin)展，探討行(xing)業發(fa)展的思(si)路和方法，以(yi)促進(jin)學術信息交流，提高行(xing)業發(fa)展。該(gai)刊(kan)已被國際權威(wei)數據庫(ku)SCIE收錄，為(wei)該(gai)領域相關學科(ke)的發(fa)展起到了良(liang)好的推動(dong)作(zuo)用，也得到了本專業人員的廣泛認可。該(gai)刊(kan)最新(xin)影響因子為(wei)15.8，最新(xin)CiteScore 指數為(wei)26.7。

本刊(kan)近期中國(guo)學者(zhe)發表的論(lun)文主要有：

• Vaccination with Span, an antigen guided by SARS-CoV-2 S protein evolution, protects against challenge with viral variants in mice

  Author: Zhao, Yongliang; Ni, Wenjia; Liang, Simeng; Dong, Lianghui; Xiang, Min; Cai, Zeng; Niu, Danping; Zhang, Qiuhan; Wang, Dehe; Zheng, Yucheng; Zhang, Zhen; Zhou, Dan; Guo, Wenhua; Pan, Yongbing; Wu, Xiaoli; Yang, Yimin; Jing, Zhaofei; Jiang, Yongzhong; Chen, Yu; Yan, Huan; Zhou, Yu; Xu, Ke; Lan, Ke

• Targeting Src reactivates pyroptosis to reverse chemoresistance in lung and pancreatic cancer models

  Author: Su, Liangping; Chen, Yitian; Huang, Cheng; Wu, Sangqing; Wang, XiaoJuan; Zhao, Xinbao; Xu, Qiuping; Sun, Ruipu; Kong, Xiangzhan; Jiang, Xue; Qiu, Xiaoyi; Huang, Xiaoming; Wang, Minghui; Wong, Ping-Pui

• CD200+cytotoxic T lymphocytes in the tumor microenvironment are crucial for efficacious anti-PD-1/PD-L1 therapy

  Author: Wang, Xinxin; Zha, Haoran; Wu, Wei; Yuan, Ting; Xie, Shuanglong; Jin, Zheng; Long, Haixia; Yang, Fei; Wang, Zhongyu; Zhang, Anmei; Gao, Jianbao; Jiang, Ying; Wang, Lujing; Hu, Chunyan; Wan, Yisong Y.; Li, Qi-Jing; Symonds, Alistair L. J.; Jia, Qingzhu; Zhu, Bo

• Epigenetic modification of CSDE1 locus dictates immune recognition of nascent tumorigenic cells

  Author: Lv, Jiadi; Zhou, Yabo; Zhou, Nannan; Wang, Zhenfeng; Chen, Jie; Chen, Haoran; Wang, Dianheng; Zhou, Li; Wei, Keke; Zhang, Huafeng; Tang, Ke; Ma, Jingwei; Liu, Yuying; Wan, Yonghong; Zhang, Yi; Zhang, Haizeng; Huang, Bo

英文介紹

Science Translational Medicine雜志英文介紹

Science Translational Medicine Mission: To promote human health by providing a forum for communication and cross-fertilization among basic, translational, and clinical research practitioners and trainees from all relevant established and emerging disciplines.

Scope: Cardiovascular disease, immunology/vaccines, metabolism/diabetes/obesity, neuroscience/neurology/psychiatry, cancer, infectious diseases, policy, behavior, bioengineering, chemical genomics/drug discovery, imaging, applied physical sciences, medical nanotechnology, drug delivery, biomarkers, gene therapy/regenerative medicine, toxicology and pharmacokinetics, data mining, cell culture, animal and human studies, medical informatics, and other interdisciplinary approaches to medicine.